TY - JOUR
T1 - Ethnobotany of the genus Taraxacum—Phytochemicals and antimicrobial activity
AU - Sharifi-Rad, Mehdi
AU - Roberts, Thomas H.
AU - Matthews, Karl R.
AU - Bezerra, Camila F.
AU - Morais-Braga, Maria Flaviana B.
AU - Coutinho, Henrique D.M.
AU - Sharopov, Farukh
AU - Salehi, Bahare
AU - Yousaf, Zubaida
AU - Sharifi-Rad, Majid
AU - del Mar Contreras, María
AU - Varoni, Elena Maria
AU - Verma, Deepa R.
AU - Iriti, Marcello
AU - Sharifi-Rad, Javad
N1 - Publisher Copyright:
© 2018 John Wiley & Sons, Ltd.
PY - 2018/11
Y1 - 2018/11
N2 - Plants belonging to the genus Taraxacum have been used in traditional healthcare to treat infectious diseases including food-borne infections. This review aims to summarize the available information on Taraxacum spp., focusing on plant cultivation, ethnomedicinal uses, bioactive phytochemicals, and antimicrobial properties. Phytochemicals present in Taraxacum spp. include sesquiterpene lactones, such as taraxacin, mongolicumin B, and taraxinic acid derivatives; triterpenoids, such as taraxasterol, taraxerol, and officinatrione; and phenolic derivatives, such as hydroxycinnamic acids (chlorogenic, chicoric, and caffeoyltartaric acids), coumarins (aesculin and cichoriin), lignans (mongolicumin A), and taraxacosides. Aqueous and organic extracts of different plant parts exhibit promising in vitro antimicrobial activity relevant for controlling fungi and Gram-positive and Gram-negative bacteria. Therefore, this genus represents a potential source of bioactive phytochemicals with broad-spectrum antimicrobial activity. However, so far, preclinical evidence for these activities has not been fully substantiated by clinical studies. Indeed, clinical evidence for the activity of Taraxacum bioactive compounds is still scant, at least for infectious diseases, and there is limited information on oral bioavailability, pharmacological activities, and safety of Taraxacum products in humans, though their traditional uses would suggest that these plants are safe.
AB - Plants belonging to the genus Taraxacum have been used in traditional healthcare to treat infectious diseases including food-borne infections. This review aims to summarize the available information on Taraxacum spp., focusing on plant cultivation, ethnomedicinal uses, bioactive phytochemicals, and antimicrobial properties. Phytochemicals present in Taraxacum spp. include sesquiterpene lactones, such as taraxacin, mongolicumin B, and taraxinic acid derivatives; triterpenoids, such as taraxasterol, taraxerol, and officinatrione; and phenolic derivatives, such as hydroxycinnamic acids (chlorogenic, chicoric, and caffeoyltartaric acids), coumarins (aesculin and cichoriin), lignans (mongolicumin A), and taraxacosides. Aqueous and organic extracts of different plant parts exhibit promising in vitro antimicrobial activity relevant for controlling fungi and Gram-positive and Gram-negative bacteria. Therefore, this genus represents a potential source of bioactive phytochemicals with broad-spectrum antimicrobial activity. However, so far, preclinical evidence for these activities has not been fully substantiated by clinical studies. Indeed, clinical evidence for the activity of Taraxacum bioactive compounds is still scant, at least for infectious diseases, and there is limited information on oral bioavailability, pharmacological activities, and safety of Taraxacum products in humans, though their traditional uses would suggest that these plants are safe.
KW - Taraxacum
KW - antibiotic resistance
KW - antimicrobial activity
KW - food preservatives
KW - functional foods
KW - nutraceuticals
UR - https://www.scopus.com/pages/publications/85052103660
U2 - 10.1002/ptr.6157
DO - 10.1002/ptr.6157
M3 - Artículo de revisión
C2 - 30039597
AN - SCOPUS:85052103660
SN - 0951-418X
VL - 32
SP - 2131
EP - 2145
JO - Phytotherapy Research
JF - Phytotherapy Research
IS - 11
ER -